Tech Company Financing Transactions
Cohera Medical Funding Round
On 10/22/2015, Cohera Medical raised $50 million in financing from KKR and private investors.
Transaction Overview
Company Name
Announced On
10/22/2015
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
KKR (Lead Investor) (Ali Satvat)
Proceeds Purpose
The Company will use the funds to launch U.S. commercial sales of TissuGlu, the first synthetic adhesive approved by the FDA for internal use. In addition, the Company intends to advance clinical trials for Sylys, an innovative surgical sealant under development for bowel repair with significant market potential.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
227 Fayetteville St. 900
Raleigh, NC 27601
USA
Raleigh, NC 27601
USA
Phone
Website
Email Address
Overview
Cohera Medical, Inc. is aimed at fulfilling the market demand for a strong, safe tissue adhesive to improve the wound closure process by positioning tissues for optimal healing while minimizing fluid accumulation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Daly
Chief Scientific Officer
Dottie Clower
Vice President
Mart Pearson
VP - Finance
Justin Alexander
VP - General Counsel
Chad Coberly
VP - Sales
John Wyatt
Browse more venture capital transactions:
Prev: 10/22/2015: Amino venture capital transaction
Next: 10/22/2015: Allay venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs